A Double-Blind, Placebo Controlled, Multicentre Study of the Efficacy And Safety of 5-Aminosalicylic Acid Tablets in the Treatment of Ulcerative Colitis
This double-blind, placebo controlled, multicentre, parallel trial assessed the efficacy of two oral doses of a new formulation of 5-aminosalicylic acid (5-ASA) targeted to release in the cecum which was given for six weeks to 136 patients with active ulcerative colitis. Seven centres participated (...
Saved in:
| Main Authors: | LR Sutherland, M Robinson, G Onstad, M Peppercorn, N Greenberger, M Goodman, F Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1990-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1990/921345 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevention of Relapse in Ulcerative Colitis Using Oral or Topical 5-Aminosalicylic Acid Therapy
by: Lloyd R Sutherland
Published: (1993-01-01) -
Efficacy and Tolerance of 5-Aminosalicylic Acid Suppositories in the Treatment of Ulcerative Proctitis: A Review of Two Double-Blind, Placebo Controlled Trials
by: CN Williams
Published: (1990-01-01) -
5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis.
by: Li-Na Zhao, et al.
Published: (2014-01-01) -
History of Previous Medication Self‐Discontinuation Predicts the Current Adherence to 5‐Aminosalicylates in Patients With Ulcerative Colitis
by: Shogo Kitahata, et al.
Published: (2025-05-01) -
Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey
by: Julajak Limsrivilai, et al.
Published: (2025-04-01)